Polyporus squamosus (Huds.) Fr. MANTARININ HPLC-DAD ANALİZİ, ANTİOKSİDAN, ANTİKOLİNESTERAZ VE ANTİDİYABETİK AKTİVİTELERİ

Yıl 2023, , 73 - 80, 31.12.2023

Gülsen Tel-çayan , Cansel Fındık

https://doi.org/10.22531/muglajsci.1336470

Öz

Polyporus türleri, tıbbi mantarlar arasında tanımlanan biyoaktif özellikleri ile Polyporaceae familyasının değerli bir türüdür. Bu çalışma, Polyporus squamosus (Huds.) Fr. mantarının antioksidan, antikolinesteraz ve antidiyabetik aktiviteleri ile HPLC-DAD ile fenolik profilinin karakterizasyonu araştırmak için yapılmıştır. Fumarik asit (190,07±0,08 µg/g), kateşin hidrat (46,96±0,02 µg/g), ferulik asit (21,98±0,03 µg/g), trans-sinnamik asit (16,66±0,02 µg/g) ve protokateşik asit (13,29±0,06 µg/g) HPLC-DAD ile P. squamosus'ta en bol bulunan bileşikler olarak tespit edilmiştir. P. squamosus metanol ekstresi β-karoten linoleik asit (IC50: 73,75±0,28 µg/mL), DPPH• giderim (400 µg/mL’de %7,56±0,00 inhibisyon), ABTS•+ giderim (IC50: 154,30±0,55 µg/mL) ve metal kelatlama (400 µg/mL’de %35,61±1,20 inhibisyon) yöntemlerinde hekzan ekstresinden daha yüksek antioksidan aktivite göstermiştir. P. squamosus hekzan ekstresi AChE enzimine karşı 200 µg/mL’de %39,48±0,45, BChE enzimine karşı 200 µg/mL’de %28,02±1,34, α-amilaz enzimine karşı 1000 µg/mL’de %96,70±0,80 ve α-glukozidaz enzimine karşı 500 µg/mL’de %39,93±0,52 inhibisyon değerleri ile metanol ekstresinden daha güçlü bir inhibitör olarak belirlenmiştir. Mevcut çalışma, P. squamosus’un sentetik ilaçlara alternatif olarak değerlendirilebilecek değerli terapötik bileşiklerin umut verici bir kaynağı olarak önemini vurgulamıştır.

Anahtar Kelimeler

Polyporus squamosus, Fenolik profil, HPLC-DAD, Antioksidan aktivite, Antikolinesteraz aktivite, Antidiyabetik aktivite

HPLC-DAD ANALYSIS, AND DETERMINATION OF ANTIOXIDANT, ANTICHOLINESTERASE AND ANTIDIABETIC ACTIVITIES OF Polyporus squamosus (Huds.) Fr.

Öz

Polyporus species is a valuable species of the Polyporaceae family with defined bioactive properties among medicinal mushrooms. This study was undertaken to investigate the antioxidant, anticholinesterase and antidiabetic activities of Polyporus squamosus (Huds.) Fr. with characterization of phenolic profile by HPLC-DAD. Fumaric acid (190.07±0.08 µg/g), catechin hydrate (46.96±0.02 µg/g), ferulic acid (21.98±0.03 µg/g), trans-cinnamic acid (16.66±0.02 µg/g), and protocatechuic acid (13.29±0.06 µg/g) were detected as the most abundant compounds in P. squamosus by HPLC-DAD. P. squamosus methanol extract exhibited higher antioxidant activity than the hexane extract in β-carotene linoleic acid (IC50: 73.75±0.28 µg/mL), DPPH• scavenging (7.56±0.00% inhibition at 400 µg/mL), ABTS•+ scavenging (IC50: 154.30±0.55 µg/mL), and metal chelating (35.61±1.20% inhibition at 400 µg/mL) assays. P. squamosus hexane extract was determined as the stronger inhibitor than the methanol extract against all enzymes with inhibition values of 39.48±0.45% on AChE at 200 µg/mL, 28.02±1.34% on BChE at 200 µg/mL, 96.70±0.80% on α-amylase at 1000 µg/mL, and 39.93±0.52% on α-glucosidase at 500 µg/mL. The present study highlighted the importance of P. squamosus as a promising source of valuable therapeutic compounds that could be considered as an alternatives to synthetic drugs.

Anahtar Kelimeler

Polyporus squamosus, Phenolic profile, HPLC-DAD, Antioxidant activity, Anticholinesterase activity, Antidiabetic activity

Kaynakça

• Kumar, K., Mehra, R., Guine R.P.F., Lima, M.J., Kumar, N., Kaushik, R., Ahmed, N., Yadav, A.N. and Kumar, H., ''Edible mushrooms: A comprehensive review on bioactive compounds with health benefits and processing aspect'', Foods, 10, 2996, 2021.
• Chopra, H., Mishra, A.K., Baig, A.A., Mohanta, T.K., Mohanta, Y.K. and Baek, K.H., ''Narrative review: Bioactive potential of various mushrooms as the treasure of versatile therapeutic natural product'', Journal of Fungi (Basel), 7(9), 728, 2021.
• Kour, H., Kour, D., Kour, S., Singh, S., Hashmi, S.A.J., Yadav, A.N., Kumar, K., Sharma, Y.P., and Ahluwalia, A.S., ''Bioactive compounds from mushrooms: Emerging bioresources of food and nutraceuticals'', Food Bioscience, 50, 102124, 2022.
• Abdelshafy, A.M., Belwal, T., Liang, Z., Wang, L., Li, D., Luo, Z. and Li, L., ''A comprehensive review on phenolic compounds from edible mushrooms: Occurrence, biological activity, application and future prospective'', Critical Reviews in Food Science and Nutrition, 62, 6204-6224, 2022.
• Bach, F., Zielinski, A.A.F., Helm, C.V., Maciel, G.M., Pedro, A.C., Stafussa, A.P., Avila, S. and Haminiuk, C.W.I., ''Bio compounds of edible mushrooms: in vitro antioxidant and antimicrobial activities'', LWT-Food Science and Technology, 107, 214-220, 2019.
• Kim, M., Ahn, C. and Kim, C., ''Major antioxidant compound of Polyporus parvovarius culture filtrate'', Natural Product Communications, 17(1), 1-5, 2022.
• Bulam, S., Üstün, N.Ş. and Pekşen, A., ''Polyporus squamosus (Huds.) Fr. in the Black Sea region'', Turkish Journal of Agriculture-Food Science and Technology, 6(2), 183-188, 2018.
• Mocan, A., Fernandes, A., Barros, L., Crişan, G., Smiljkovic, M., Sokovic, M. and Ferreira, I.C.F.R., ''Chemical composition and bioactive properties of the wild mushroom Polyporus squamosus (Huds.) Fr: A study with samples from Romania'', Food & Function, 9, 160, 2018.
• World Health Organization (WHO), Insulin and associated devices: Access for everybody, WHO stakeholder workshop, Switzerland, WHO Press, 2020.
• Erol, Ö., Ünsar, S. and Yacan, L., ''Determination of physical activity behaviors and well-being of ındividuals with diabetes mellitus'', Turkish Journal of Diabetes and Obesity, 1, 49-58, 2022.
• Przeor, M., ''Some common medicinal plants with antidiabetic activity, known and available in Europe (A mini-review)'', Pharmaceuticals, 15, 65, 2022.
• Jovanovic, A.J., Mihailovic, M., Uskokovic, A., Grdovic, N., Dinic, S. and Vidakovic, M., ''The effects of major mushroom bioactive compounds on mechanisms that control blood glucose level'', Journal of Fungi (Basel), 7(1), 58, 2021.
• Breijyeh, Z. and Karaman, R., ''Comprehensive review on Alzheimer’s disease: Causes and treatment'', Molecules, 25(24), 5789, 2020.
• Madnani, R.S., ''Alzheimer’s disease: A minireview for the clinician'', Frontiers in Neurology, 14, 1178588, 2023.
• Koly, H.K., Sutradhar, H. and Rahman, M.S., ''Acetylcholinesterase inhibition of Alzheimer’s disease: identification of potential phytochemicals and designing more effective derivatives to manage disease condition'', Journal of Biomolecular Structure and Dynamics, 2022. https://doi.org/10.1080/07391102.2023.2166992.
• Alam, M.N., Bristi, N.J. and Rafiquzzaman, M., ''Review on in vivo and in vitro methods evaluation of antioxidant activity'', Saudi Pharmaceutical Journal, 21, 143-152, 2013.
• Kotha, R.R., Tareq, F.S., Yildiz, E. and Luthria, D.L., ''Oxidative stress and antioxidants-a critical review on in vitro antioxidant assays'', Antioxidants, 11(12), 2388, 2022.
• Barros, L., Duenas, M., Ferreira, I.C.F.R., Baptista, P. and Santos-Buelga, C., ''Phenolic acids determination by HPLC–DAD–ESI/MS in sixteen different Portuguese wild mushrooms species'', Food and Chemical Toxicology, 47, 1076-1079, 2009.
• Tel-Çayan, G., ''Phenolic profiles, antioxidant, and anticholinesterase activities of three Gloeophyllum species with chemometric approach'', Journal of Food Biochemistry, 43(4), e12790, 2019.
• Çayan, F., Tel-Çayan, G., Deveci, E., Öztürk, M. and Duru, M.E., ''Chemical profile, in vitro enzyme inhibitory, and antioxidant properties of Stereum species (Agaricomycetes) from Turkey'', International Journal of Medicinal Mushrooms, 21(11), 1075-1087, 2019.
• Çayan, F., Tel‐Çayan, G., Deveci, E., Duru, M.E. and Türk, M., ''A detailed study on multifaceted bioactivities of the extracts and isolated compounds from truffle Reddellomyces parvulosporus'', International Journal of Food Science & Technology, 57(3), 1411-1419, 2022.
• Nwozo, O.S., Effiong, E.M., Aja, P.M. and Awuchi, C.G., ''Antioxidant, phytochemical, and therapeutic properties of medicinal plants: A review'', International Journal of Food Properties, 26(1), 359-388, 2023.
• Shakya, A., Singh, G.K., Chatterjee, S.S. and Kumar, V., ''Role of fumaric acid in anti-inflammatory and analgesic activities of a Fumaria indica extracts'', Journal of Intercultural Ethnopharmacology, 3, 173-178, 2014.
• Bae, J., Kim, N., Shin, Y., Kim, S.Y. and Kim, Y.J., ''Activity of catechins and their applications'', Biomedical Dermatology, 4, 8, 2020.
• Li, D., Rui, Y.X., Guo, S.D., Luan, F., Liu, R. and Zeng, N., ''Ferulic acid: A review of its pharmacology, pharmacokinetics and derivatives'', Life Sciences, 284, 119921, 2021.
• Kakkar, S. and Bais, S., ''A review on protocatechuic acid and its pharmacological potential'', ISRN Pharmacology, 2014, 952943, 2014.
• Ruwizhi, N. and Aderibigbe, B.A. ''Cinnamic acid derivatives and their biological efficacy'', International Journal of Molecular Sciences, 21(16), 5712, 2020.
• Fernandes, A., Petrovic, J.., Stojkovic, D., Barros, L., Glamoclija, J. Sokovic, M., Martins, A. and Ferreira, I.C.F.R., ''Polyporus squamosus (Huds.) Fr from different origins: Chemical characterization, screening of the bioactive properties and specific antimicrobial effects against Pseudomonas aeruginosa'', LWT-Food Science and Technology, 69, 91-97, 2016.
• Tel-Çayan, G., Çayan, F., Deveci, E. and Duru, M.E., ''Phenolic profile, antioxidant and cholinesterase inhibitory activities of four Trametes species: T. bicolor, T. pubescens, T. suaveolens, and T. versicolor'', Journal of Food Measurement and Characterization, 15, 4608-4616, 2021.
• Zengin, G., Karanfil, A., Uren, M.C., Kocak, M.S., Sarikurkcu, C., Gungor, H., Picot, C.M.N. and Mahomoodally, M.F., ''Phenolic content, antioxidant and enzyme inhibitory capacity of two Trametes species'', RSC Advances, 6, 73351-73357, 2016.
• Alara, O.R., Abdurahman, N.H. and Ukaegbu, C.I., ''Extraction of phenolic compounds: A review'', Current Research in Food Science, 4, 200-214, 2021.
• Krishnaiah, D., Sarbatly, R. and Nithyanandam, R., ''A review of the antioxidant potential of medicinal plant species'', Food and Bioproducts Processing, 89, 217-233, 2011.
• Elmastas, M., Isildak, O., Turkekul, I. and Temur, N., ''Determination of antioxidant activity and antioxidant compounds in wild edible mushrooms'', Journal of Food Composition and Analysis, 20, 337-345, 2007.
• Akata, I., Ergönül, B. and Kalyoncu, F., ''Chemical compositions and antioxidant activities of 16 wild edible mushroom species grown in Anatolia'', International Journal of Pharmacology, 8(2), 134-138, 2012.
• Dimitrijevic, M., Jovanovic, V.S., Cvetkovic, J., Mihajilov-Krstev, T., Stojanovic, G. and Mitica, V., ''Screening of antioxidant, antimicrobial and antiradical activities of twelve selected Serbian wild mushrooms'', Analytical Methods, 7, 4181, 2015.
• Orhan, I. and Üstün, O., ''Determination of total phenol content, antioxidant activity and acetylcholinesterase inhibition in selected mushrooms from Turkey'', Journal of Food Composition and Analysis, 24, 386-390, 2011.
• Holdgate, G.A., Meek, T.D. and Grimley, R.L., ''Mechanistic enzymology in drug discovery: a fresh perspective'', Nature Reviews Drug Discovery, 17, 115-132, 2018.
• Angelini, P., Venanzoni, R., Flores, G.A., Tirillini, B., Orlando, G., Recinella, L., Chiavaroli, A., Brunetti, L., Leone, S., Di Simone, S.C., Ciferri, M.C., Zengin, G., Ak, G., Menghini, L. and Ferrante, C., ''Evaluation of antioxidant, antimicrobial and tyrosinase inhibitory activities of extracts from Tricholosporum goniospermum, an edible wild mushroom'', Antibiotics, 9, 513, 2020.
• Çayan, F., Tel-Çayan, G., Deveci, E. and Duru, M.E., ''HPLC-DAD characterization of phenolic profile and in vitro antioxidant, anticholinesterase, and antidiabetic activities of five mushroom species from Turkey'', 3 Biotech, 11(6), 273, 2021.
• Snowden, S.G., Ebshiana, A.A., Hye, A., An, Y., Pletnikova, O., O’Brien, R., Troncoso, J., Legido-Quigley, C. and Thambisetty, M., ''Association between fatty acid metabolism in the brain and Alzheimer disease neuropathology and cognitive performance: A nontargeted metabolomic study'', PLOS Medicine, 14(3), e1002266, 2017.
• Li, X., Bai, Y., Jin, Z. and Svensson, B., ''Food-derived non-phenolic α-amylase and α-glucosidase inhibitors for controlling starch digestion rate and guiding diabetes-friendly recipes'', LWT-Food Science and Technology, 53, 112455, 2022.
• Deveci, E., Çayan, F., Tel-Çayan, G. and Duru, M.E., ''Inhibitory activities of medicinal mushrooms on α-amylase and α-glucosidase-enzymes related to type 2 diabetes'', South African Journal of Botany, 137, 19-23, 2021.